|
1
|
Corless CL, Fletcher JA and Heinrich MC:
Biology of gastrointestinal stromal tumors. J Clin Oncol.
22:3813–3825. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rubin BP, Singer S, Tsao C, Duensing A,
Lux ML, Ruiz R, Hibbard MK, Chen CJ, Xiao S, Tuveson DA, et al: KIT
activation is a ubiquitous feature of gastrointestinal stromal
tumors. Cancer Res. 61:8118–8121. 2001.PubMed/NCBI
|
|
3
|
Corless CL and Heinrich MC: Molecular
pathobiology of gastrointestinal stromal sarcomas. Annu Rev Pathol.
3:557–586. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Corless CL, Barnett CM and Heinrich MC:
Gastrointestinal stromal tumours: Origin and molecular oncology.
Nat Rev Cancer. 11:865–878. 2011.PubMed/NCBI
|
|
5
|
Duensing A, Medeiros F, McConarty B,
Joseph NE, Panigrahy D, Singer S, Fletcher CD, Demetri GD and
Fletcher JA: Mechanisms of oncogenic KIT signal transduction in
primary gastrointestinal stromal tumors (GISTs). Oncogene.
23:3999–4006. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Heinrich MC, Corless CL, Demetri GD,
Blanke CD, von Mehren M, Joensuu H, McGreevey LS, Chen CJ, Van den
Abbeele AD, Druker BJ, et al: Kinase mutations and imatinib
response in patients with metastatic gastrointestinal stromal
tumor. J Clin Oncol. 21:4342–4349. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Morisaki T, Sabina RL and Holmes EW:
Adenylate deaminase. A multigene family in humans and rats. J Biol
Chem. 265:11482–11486. 1990.PubMed/NCBI
|
|
8
|
Mahnke DK and Sabina RL: Calcium activates
erythrocyte AMP deaminase [isoform E (AMPD3)] through a
protein-protein interaction between calmodulin and the N-terminal
domain of the AMPD3 polypeptide. Biochemistry. 44:5551–5559. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mahnke-Zizelman DK and Sabina RL: Cloning
of human AMP deaminase isoform E cDNAs. Evidence for a third AMPD
gene exhibiting alternatively spliced 5′-exons. J Biol Chem.
267:20866–20877. 1992.PubMed/NCBI
|
|
10
|
Coley W, Rayavarapu S, Pandey GS, Sabina
RL, Van der Meulen JH, Ampong B, Wortmann RL, Rawat R and Nagaraju
K: The molecular basis of skeletal muscle weakness in a mouse model
of inflammatory myopathy. Arthritis Rheum. 64:3750–3759. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
van Adel BA and Tarnopolsky MA: Metabolic
myopathies: Update 2009. J Clin Neuromuscul Dis. 10:97–121. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Akizu N, Cantagrel V, Schroth J, Cai N,
Vaux K, McCloskey D, Naviaux RK, Van Vleet J, Fenstermaker AG,
Silhavy JL, et al: AMPD2 regulates GTP synthesis and is mutated in
a potentially treatable neurodegenerative brainstem disorder. Cell.
154:505–517. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yamada Y, Goto H, Wakamatsu N and
Ogasawara N: A rare case of complete human erythrocyte AMP
deaminase deficiency due to two novel missense mutations in AMPD3.
Hum Mutat. 17:782001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cheng J, Morisaki H, Toyama K, Ikawa M,
Okabe M and Morisaki T: AMPD3-deficient mice exhibit increased
erythrocyte ATP levels but anemia not improved due to PK
deficiency. Genes Cells. 17:913–922. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Desman G, Waintraub C and Zippin JH:
Investigation of cAMP microdomains as a path to novel cancer
diagnostics. Biochim Biophys Acta. 1842:2636–2645. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fu QF, Liu Y, Fan Y, Hua SN, Qu HY, Dong
SW, Li RL, Zhao MY, Zhen Y, Yu XL, et al: Alpha-enolase promotes
cell glycolysis, growth, migration, and invasion in non-small cell
lung cancer through FAK-mediated PI3K/AKT pathway. J Hematol Oncol.
8:222015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pantano F, Santoni M, Procopio G, Rizzo M,
Iacovelli R, Porta C, Conti A, Lugini A, Milella M, Galli L, et al:
The changes of lipid metabolism in advanced renal cell carcinoma
patients treated with everolimus: A new pharmacodynamic marker?
PLoS One. 10:e01204272015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen H, Wang JP, Santen RJ and Yue W:
Adenosine monophosphate activated protein kinase (AMPK), a mediator
of estradiol-induced apoptosis in long-term estrogen deprived
breast cancer cells. Apoptosis. 20:821–830. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shieh JM, Chen YC, Lin YC, Lin JN, Chen
WC, Chen YY, Ho CT and Way TD: Demethoxycurcumin inhibits energy
metabolic and oncogenic signaling pathways through AMPK activation
in triple-negative breast cancer cells. J Agric Food Chem.
61:6366–6375. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang J, Wang Y, Shang D, Yu F, Liu W,
Zhang Y, Feng C, Wang Q, Xu Y, Liu Y, et al: Characterizing and
optimizing human anticancer drug targets based on topological
properties in the context of biological pathways. J Biomed Inform.
54:132–140. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rhodes DR, Yu J, Shanker K, Deshpande N,
Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM:
ONCOMINE: A cancer microarray database and integrated data-mining
platform. Neoplasia. 6:1–6. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Taguchi T, Sonobe H, Toyonaga S, Yamasaki
I, Shuin T, Takano A, Araki K, Akimaru K and Yuri K: Conventional
and molecular cytogenetic characterization of a new human cell
line, GIST-T1, established from gastrointestinal stromal tumor. Lab
Invest. 82:663–665. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Buleje J, Acosta Ó, Guevara-Fujita M,
Enriquez Y, Taxa L, Machicado E, Lizaraso-Caparó F and Fujita R:
Mutational profile of KIT and PDGFRA genes in gastrointestinal
stromal tumors in Peruvian samples. Rev Esp Enferm Dig. 107:72–78.
2015.PubMed/NCBI
|
|
24
|
Comandone A and Boglione A: The importance
of mutational status in prognosis and therapy of GIST. Recenti Prog
Med. 106:17–22. 2015.(In Italian). PubMed/NCBI
|
|
25
|
Joensuu H, Rutkowski P, Nishida T, Steigen
SE, Brabec P, Plank L, Nilsson B, Braconi C, Bordoni A, Magnusson
MK, et al: KIT and PDGFRA mutations and the risk of GI stromal
tumor recurrence. J Clin Oncol. 33:634–642. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ran L, Sirota I, Cao Z, Murphy D, Chen Y,
Shukla S, Xie Y, Kaufmann MC, Gao D, Zhu S, et al: Combined
inhibition of MAP kinase and KIT signaling synergistically
destabilizes ETV1 and suppresses GIST tumor growth. Cancer Discov.
5:304–315. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang Y, Gu ML, Zhou XX, Ma H, Yao HP and
Ji F: Altered expression of ETV1 and its contribution to
tumorigenic phenotypes in gastrointestinal stromal tumors. Oncol
Rep. 32:927–934. 2014.PubMed/NCBI
|
|
28
|
Liang J, Wu YL, Chen BJ, Zhang W, Tanaka Y
and Sugiyama H: The C-kit receptor-mediated signal transduction and
tumor-related diseases. Int J Biol Sci. 9:435–443. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu K: Stem cell factor (SCF)-kit mediated
phosphatidylinositol 3 (PI3) kinase signaling during mammalian
oocyte growth and early follicular development. Front Biosci.
11:126–135. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kim A, Im M and Ma JY: Ethanol extract of
Remotiflori radix induces endoplasmic reticulum stress-mediated
cell death through AMPK/mTOR signaling in human prostate cancer
cells. Sci Rep. 5:83942015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Schuster S, Penke M, Gorski T, Gebhardt R,
Weiss TS, Kiess W and Garten A: FK866-induced NAMPT inhibition
activates AMPK and downregulates mTOR signaling in hepatocarcinoma
cells. Biochem Biophys Res Commun. 458:334–340. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Popovics P, Frigo DE, Schally AV and Rick
FG: Targeting the 5′-AMP-activated protein kinase and related
metabolic pathways for the treatment of prostate cancer. Expert
Opin Ther Targets. 19:617–632. 2015. View Article : Google Scholar : PubMed/NCBI
|
